EGFR-targeted immunoliposomes derived from the monoclonal antibody EMD72000 mediate specific and efficient drug delivery to a variety of colorectal cancer cells

Author： Mamot Christoph   Ritschard Reto   Küng Willy   Park John W.   Herrmann Richard   Rochlitz Christoph F.  

Publisher： Informa Healthcare

ISSN： 1061-186X

Source： Journal of Drug Targeting, Vol.14, Iss.4, 2006-05, pp. : 215-223

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Antibody-Targeted Immunoliposomes for Cancer Treatment

By  

Mini Reviews in Medicinal Chemistry, Vol. 13, Iss. 14, 2013-12 ,pp. : 2026-2035

Bentham Science Publishers

Access to resources Recommend Favorite

Nanomaterials for targeted drug delivery to cancer stem cells

By Orza Anamaria   Casciano Daniel   Biris Alexandru  

Drug Metabolism Reviews, Vol. 46, Iss. 2, 2014-05 ,pp. : 191-206

Informa Healthcare

Access to resources Recommend Favorite

Development of Pulsatile Systems for Targeted Drug Delivery of Celecoxib for Prophylaxis of Colorectal Cancer

By Sinha V.   Bhinge J.   Kumria Rachna   Kumar Manoj  

Drug Delivery, Vol. 13, Iss. 3, 2006-05 ,pp. : 221-225

Informa Healthcare

Access to resources Recommend Favorite

EGFR-Targeted Therapy in Malignant Glioma: Novel Aspects and Mechanisms of Drug Resistance

By  

Current Molecular Pharmacology, Vol. 3, Iss. 1, 2010-01 ,pp. : 37-52

Bentham Science Publishers

Access to resources Recommend Favorite

EGFR-targeted therapies in lung cancer: predictors of response and toxicity

By Heist Rebecca Suk   Christiani David  

Pharmacogenomics, Vol. 10, Iss. 1, 2009-01 ,pp. : 59-68

Future Medicine

Access to resources Recommend Favorite